Update on Funding

14th Apr 2026 07:00

RNS Number : 3575A
Directa Plus PLC
14 April 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

14 April 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Update on Funding

 

Further to the notification of 13 April 2026, the board of Directa Plus confirms that in light of the developments announced yesterday, the potential funding facility Principal, as first announced on 30 March 2026, is not capable of being progressed with the institutional investor at this time.

Further announcements will be made as appropriate.

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

For further information, please contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

 

Singer Capital Markets (Nominated Adviser and Broker)

+44 20 7496 3000

Rick Thompson / Phil Davies/Carl Diebitsch

 

Alma Strategic Communications (Financial PR Adviser)

+44 20 3405 0205

Justine James / Hannah Campbell / Rose Docherty

[email protected]

 

 

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomaz (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFWSILEMSEDL